“Business Russia” supports the proposal of FAS to modify “odd man out” rule

| By | Drug Procurement, FAS Russia

Russian Public Organization “Delovaya Rossiya” (“Business Russia”) supports the proposal of the Federal Antimonopoly Service (FAS) to abolish the prohibitive principle of the “odd man out” rule in the public procurement of drugs by modifying it into the system of price preferences, as this will improve the competitiveness of pharmaceutical industry and reduce the budgetary expenditures of the Russian Federation, said Alexey Repik, the head of the business association.

“We support the proposal of FAS to modify the system of restrictions and transform the “odd man out” rule into price preferences. In the short term, this will improve the competitiveness of Russian products and reduce the risks for health care budgets at all levels. But the imposition of additional restrictions (three-stage model of preferences) will drastically change the rules for participants in the pharmaceutical market, which will have a negative effect,” said Mr. Repik.